Literature DB >> 34917443

Spermatic Cord Liposarcoma: A Case Report and Review of the Literature on the Role of Radiotherapy and Chemotherapy in Preventing Locoregional Recurrence.

Olisaemeka D Ogbue1, Abdo Haddad2, Hamed Daw2.   

Abstract

Spermatic cord cancer is a rare entity. Among malignant tumors of the spermatic cord, liposarcomas are the most common type, often presenting as painless slow-growing masses usually in the fifth and sixth decades of life; they can be misdiagnosed as inguinal hernia or hydrocele. Radical orchiectomy with wide local soft tissue resection is an accepted standard of care for spermatic cord liposarcoma and has been curative in some cases. There is no definitive role for other treatment modalities such as chemotherapy, retroperitoneal lymph node dissection (RPLND), and radiotherapy. We present a case of liposarcoma of the spermatic cord managed with radical orchiectomy, wide local excision, and was followed up without disease recurrence. We also engage in a review of the literature on the role of systemic chemotherapy and radiotherapy in preventing locoregional recurrence after primary surgery. A combination of surgery and postoperative radiotherapy is effective in preventing locoregional spread. Data from case reports support this strategy in certain histologic subtypes or when margins are positive after primary surgery. A follow-up period of up to a decade after surgery is recommended.
Copyright © 2021, Ogbue et al.

Entities:  

Keywords:  chemotherapy; radiotherapy (rt); spermatic cord tumors; well-differentiated liposarcoma; wide resection

Year:  2021        PMID: 34917443      PMCID: PMC8670550          DOI: 10.7759/cureus.19567

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

1.  Safety and efficacy of intensity-modulated radiotherapy in the management of spermatic cord sarcoma.

Authors:  T Cerda; É Martin; G Truc; G Créhange; P Maingon
Journal:  Cancer Radiother       Date:  2016-12-29       Impact factor: 1.018

2.  The management of spermatic cord sarcoma.

Authors:  M A Fagundes; A L Zietman; A F Althausen; J J Coen; W U Shipley
Journal:  Cancer       Date:  1996-05-01       Impact factor: 6.860

3.  Spermatic cord sarcoma in adults.

Authors:  P C Sogani; H Grabstald; W F Whitmore
Journal:  J Urol       Date:  1978-09       Impact factor: 7.450

4.  Liposarcoma of spermatic cord.

Authors:  D E Johnson; J D Harris; A G Ayala
Journal:  Urology       Date:  1978-02       Impact factor: 2.649

5.  Spermatic cord sarcoma: outcome, patterns of failure and management.

Authors:  M T Ballo; G K Zagars; P W Pisters; B W Feig; S R Patel; A C von Eschenbach
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

6.  Dedifferentiated spermatic cord liposarcoma with macroscopic ossification.

Authors:  Takashi Ando; Ryo Nakayama; Takaki Mizusawa; Takeshi Sakai; Hiroshi Otsuka; Akiyoshi Katagiri
Journal:  IJU Case Rep       Date:  2018-09-06

7.  Management of spermatic cord tumors: a rare urologic malignancy.

Authors:  Dayron Rodríguez; Aria F Olumi
Journal:  Ther Adv Urol       Date:  2012-12

8.  Testicular, Spermatic Cord, and Scrotal Soft Tissue Sarcomas: Treatment Outcomes and Patterns of Failure.

Authors:  Varun K Chowdhry; John M Kane; Katy Wang; Daniel Joyce; Anne Grand'Maison; Gary N Mann
Journal:  Sarcoma       Date:  2021-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.